• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

ws.lee@unimelb.edu.au

Credentials


Position
Research Fellow
Department of Microbiology and Immunology
Education
PhD
University of Melbourne
ORCID

0000-0001-7285-4054

Dr Wen Shi Lee

Research Fellow
Department of Microbiology and Immunology

70 Scholarly works
5 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Evaluating southern pigtail macaques as an immunological model for human antibody responses
    DOI: 10.1038/s41598-026-42695-6
  • 2026

    Journal article

    Delivery of monoclonal antibodies using mRNA lipid nanoparticles confers protection against SARS-CoV-2 and influenza
    DOI: 10.1016/j.omtn.2026.102873
  • 2026

    Journal article

    Immune responses associated with protection from SARS-CoV-2 infection
    DOI: 10.1016/j.vaccine.2026.128579
  • 2024

    Research grants (ARC, NHMRC, MRFF)

    Harnessing Antiviral Antibodies for Pandemic Preparedness
  • 2023

    Research grants (other domestic)

    Monoclonal Antibodies to Treat and Prevent Orthopoxvirus and Henipavirus Pandemic Threats
  • 2021

    Journal article

    Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: Implications for COVID-19 pathogenesis and consequences
    DOI: 10.1183/13993003.03730-2020
  • 2020

    Research Grant

    “Immunity Passport” to COVID19
Wen Shi Lee

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Elevated SARS-CoV-2 IgG4 in plasma and mucosa following repeated mRNA boosters impact antibody functions to Omicron and sarbecoviruses
    DOI: 10.1016/j.ebiom.2025.106087
  • 2025

    Journal article

    Potent neutralising monoclonal antibodies targeting the spike of NL63 coronavirus
    DOI: 10.1038/s44298-025-00116-x
  • 2025

    Journal article

    Modulation of germinal center and antibody dynamics via ipsilateral versus contralateral immunization against SARS-CoV-2
    DOI: 10.1093/jimmun/vkae067
  • 2025

    Journal article

    Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccines
    DOI: 10.1172/jci.insight.187075
  • 2025

    Journal article

    Mucosal vaccination against SARS-CoV-2 using recombinant influenza viruses delivering self-assembling nanoparticles
    DOI: 10.1016/j.vaccine.2024.126668
  • 2025

    Journal article

    Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variant
    DOI: 10.1126/sciadv.ads1482
  • 2025

    Conference Proceedings

    Chimeric coronavirus spike combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent T helper cell and neutralising antibody responses in murine and non-human primate models 4642
    DOI: 10.1093/jimmun/vkaf283.2295

RECENT PROJECTS

  • 2022

    Internal Research Grant

    Future-Proofing Human Populations Against COVID-19

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224